Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 9—September 2024
Research Letter

Association of Intestinal Helminthiasis with Disseminated Leishmaniasis, Brazil

Brady PageComments to Author , Alexsandro Lago, and Edgar M. Carvalho
Author affiliations: University of California–San Diego, La Jolla, California, USA (B. Page); Scripps Research Institute, La Jolla (B. Page); Universidade Federal da Bahia, Salvador, Brazil (A. Lago, E.M. Carvalho); Instituto Nacional de Ciências e Tecnologia para Doenças Tropicais, Brasília, Brazil (E.M. Carvalho); Fundação Oswaldo Cruz, Salvador (E.M. Carvalho)

Main Article

Table

Comparison of characteristics of patients with cutaneous and disseminated leishmaniasis, with and without intestinal helminthiasis, Brazil, 2017

Characteristic All patients
 Patients with disseminated leishmaniasis
Cutaneous leishmaniasis Disseminated leishmaniasis p value With intestinal helminthiasis Without intestinal helminthiasis p value
Total no. patients
 99
 30
8
 12
Median age, y (range)
 24 (13–56)
 42 (18–69)
 0.02*
37.5 (24–65)
 49.5 (18–69)
 0.6*
Sex, no. (%)
M 76 (76.8) 15 (75) 1† 6 (75) 8 (67) 1†
F
 23 (23.4)
 5 (25)
2 (25)
 4 (33)
Median duration of illness, d (range)
 40 (20–60)
 30 (15–90)
 0.18*
40 (20–90)
 30 (15–90)
 0.43*
Median no. lesions (range) 1 (1–8) 35.5 (11–1,500) <0.05* 46 (11–1,500) 27 (12–102) 0.8*
Median area of largest lesion, mm2 (range)
 224 (15–3,016)
 260.5 (16–16,160)
 0.3*
240 (36–16,160)
 260.5 (16–1,280)
 0.57*
Helminths present, % (no.) 40 (40/99) 40 (8/20) 1†
Median no. helminth ova present on fecal microscopy (range)
 6 (1–4,000)
 60 (1–288)
 0.08*
Cure rate at 90 d, % (no. patients) 65.9 (60/91) 30 (6/20) 0.003* 25 (2/8) 33 (4/12) 0.78*
Median time to cure, d (range) 65 (17–390) 154.5 (45–800) <0.001* 184.5 (60–800) 140 (45–540) 0.46*

*Significance assessed by Mann-Whitney U test. †Significance assessed by χ2 test.

Main Article

Page created: July 30, 2024
Page updated: August 15, 2024
Page reviewed: August 15, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external